导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -30.52% | 4748/4773 |
| 近一周 | -3.19% | 4621/5465 |
| 近一月 | -5.66% | 3831/5421 |
| 近一季 | -13.11% | 4101/5231 |
| 近半年 | -28.75% | 4888/4920 |
| 近一年 | -34.57% | 4332/4394 |
| 近两年 | -5.12% | 2934/2954 |
| 近三年 | -0.77% | 1938/2253 |
| 成立以来 | 70.58% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.61% 3893/4961 |
-22.71% 4923/5312 |
- - |
- - |
| 2025 | 1.89% 3212/4813 |
-0.14% 2080/3635 |
-2.74% 3371/4076 |
12.51% 3068/4524 |
-6.75% 3730/4813 |
| 2024 | 35.34% 58/3463 |
6.96% 269/2808 |
0.88% 529/3014 |
13.89% 2081/3129 |
10.13% 289/3463 |
| 2023 | 7.39% 146/2656 |
2.17% 1421/2280 |
0.30% 328/2385 |
2.16% 250/2515 |
2.57% 63/2655 |
| 2022 | -20.40% 969/2207 |
-21.82% 1655/1919 |
34.21% 2/2016 |
-21.44% 1904/2113 |
-3.43% 1849/2208 |
| 2021 | 10.63% 425/1822 |
-14.94% 1184/1255 |
30.49% 38/1330 |
0.05% 473/1466 |
-0.38% 1229/1822 |
| 2020 | 78.54% 45/1250 |
-0.76% 192/1028 |
3.51% 938/1067 |
28.01% 18/1164 |
35.78% 14/1184 |
| 2019 | 11.89% 722/1092 |
18.08% 649/739 |
-4.86% 435/788 |
-3.17% 730/850 |
2.85% 857/918 |
| 2018 | -32.88% 542/834 |
- - |
-12.37% 392/631 |
-7.01% 426/660 |
-11.27% 275/682 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 广发中证全指汽车指数C VS. 长安沪深300非周期A(740101) |